Menu Close

Articles on TB

Displaying 1 - 20 of 58 articles

COVID-19 has not been as devastating in South Africa as initially feared. Dino Lloyd/Gallo Images via Getty Images

COVID-19 and HIV: so far it seems the outcome is not what was feared

Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively 'low' numbers of COVID-19 infections and mortality in people with HIV in South Africa.
A healthcare worker in a protective suit is seen at a quarantine and isolation centre in Johannesburg, South Africa.

How COVID-19 threatens efforts to contain HIV/AIDS in South Africa

The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.
Misha Jordaan/Gallo Images via Getty Images

The new architectural frontier: buildings and their microbiomes

The study of two hospitals was a first for researching the microbiology of the built environment in South Africa – a multi-disciplinary approach to understanding how to design healthier buildings.
Fluorescence microscopy of mycobacteria. Michael A. Reiche, Timothy J. de Wet, Ryan Dinkele and Digby F. Warner

TB: scientists know a great deal, but there’s still more to learn

Scientists need greater understanding of the bacterium's basic biology, as well as more about how it is spread from one individual to the next.
Ageing increases the risk of non-communicable diseases. Shutterstock

Taking the long view on health: tracking the impact of ageing in rural South Africa

Rapid population ageing has prompted researchers to study disease trends in older South Africans. The aim is to understand the role that specific health conditions play in ageing among rural people.
A girl takes her tuberculosis medication under the supervision of a health worker in Himachal Pradesh, India. (WHO/M.Grzemska)

A human-rights approach is essential to end the global TB epidemic

Tuberculosis kills more people globally than any other infectious disease. A human-rights approach and investment in quality care are essential to ending the global epidemic.
New research holds promise of a shorter treatment course for people with drugresistant- TB. Daniel Irungu/EPA

Drug-resistant TB: a new study offers new hope

New research shows that the treatment of drug resistant-TB can be reduced from the current duration of 20 to 24 months to less than a year.

Top contributors

More